EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy

Thijs T Jansz, Katherine G Young, Martha M Dinsdale, Pedro Cardoso, Richard A Oram, John M Dennis

The Lancet Primary Care · 2026-08 · 2 (8) · 100201

DOI: 10.1016/j.lanprc.2026.100201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-08. Verfasst von Thijs T Jansz und 5 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We thank Dion Groothof and colleagues for their interest in our work.1 The authors raise the possibility that GLP-1 receptor agonists might result in muscle loss and that such body composition changes might influence estimates of the glomerular filtration rate (GFR). We agree that this point warrants consideration when interpreting estimated GFR (eGFR)-based outcomes. We also agree that further mechanistic studies incorporating measured GFR alongside assessments of body composition would help to better characterise the kidney outcomes as a result of incretin-based therapies, both as monotherapy and in combination with SGLT2 inhibitors.

Förderung

  • UK Research and Innovation Medical Research Council

Zitieren

APA

Jansz, T. T., Young, K. G., Dinsdale, M. M., Cardoso, P., Oram, R. A., & Dennis, J. M. (2026). Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy. The Lancet Primary Care, 2(8), 100201. https://doi.org/10.1016/j.lanprc.2026.100201

Vancouver

Jansz TT, Young KG, Dinsdale MM, Cardoso P, Oram RA, Dennis JM. Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy. The Lancet Primary Care. 2026;2(8):100201. doi:10.1016/j.lanprc.2026.100201

BibTeX
@article{Jansz2026,
  author = {Jansz, Thijs T and Young, Katherine G and Dinsdale, Martha M and Cardoso, Pedro and Oram, Richard A and Dennis, John M},
  title = {Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy},
  journal = {The Lancet Primary Care},
  year = {2026},
  volume = {2},
  number = {8},
  pages = {100201},
  doi = {10.1016/j.lanprc.2026.100201}
}
Kostenlos starten →